Filing Details

Accession Number:
0001209191-15-055745
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-23 19:20:19
Reporting Period:
2015-06-16
Filing Date:
2015-06-23
Accepted Time:
2015-06-23 19:20:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1557421 Ignyta Inc. RXDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1455228 W. Alexander Casdin C/O Ignyta, Inc.
11111 Flintkote Avenue
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-16 65,714 $17.50 474,464 No 4 P Indirect By Reneo Capital SPV I LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Reneo Capital SPV I LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 100,000 Direct
Footnotes
  1. The Reporting Person is the Managing Member of Reneo GP, LLC, which is the General Partner of Reneo Capital SPV I LP, and as such the Reporting Person and Reneo GP, LLC have the power to vote or dispose of the securities held of record by the Reporting Person and may be deemed to beneficially own those securities. The Reporting Person disclaims beneficial ownership of the securities held of record by Reneo Capital SPV I LP except to the extent of his pecuniary interest therein.